Everotas 5mg tablet - Everolimus | Apple Pharmaceuticals

Description

Everotas 5mg consists of an active ingredient known as Everolimus which is intruded with the growth of cancer cell and the process is slowed down.
Everotas 5mg tablets is not a curable medication, which helps to slow their spreading into the body.

Indication

 Primarily Everotas 5mg tablets indicated for the treatment
* kidney carcinoma
* Breast carcinoma
* Brain carcinoma
Everolimus is also indicated in various advanced stage cancer in stomach, intestines or pancreas.

Mechanism

Everolimus is an inhibitor of mTOR, joins at high compatibility to FK506 binding protein 12, via producing drug complex that inhibits the production of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis

Dosage and administration

Everotas 5mg tablets should be given with or without food.
Dosage regimen of Everotas 5mg:
In breast cancer, renal cell cancer, pancreatic cancer, Neuroendocrine cancer:
The prescribed dosage is 10mg should be taken as a single dose.
In Brain or intracranial cancer:
The prescribed dosage of Everotas as a single dose. is 4.5mg/m2 given orally
In pediatric:
The pediatric dosage of Everotas as a single dose in the brain or intracranial tumor is 4.5mg/m2 should be given orally.

Side Effects

Hypersensitivity reactions, Lymphomas & other malignancy, Serious infections, Kidney graft thrombosis, Hepatic artery thrombosis, Nephrotoxicity, Hyperlipemia, Angioedema, Interstitial lung disease, Thrombocytopenia, Male infertility, Proteinuria, New commencement of diabetes.

Drug interaction

Everotas 5mg interaction with strong inhibitor of CYP3A4, or P-g p, cause reducing the efflux of Everolimus and high plasma concentration of Everolimus.
Interaction of Everotas 5mg with strong CYP3A4 inducers will be increasing the disclosure of Everolimus.
Combination of Everotas 5mg with cyclosporine will increase the AUC level of Everolimus frequently.
Combination ketoconazole with Everotas 5mg tablet or other CYP3A4 inhibitors will be increasing the plasma concentration and AUC of Everolimus.

Pregnancy and lactation

Pregnancy category of Everolimus C
In patients, Everotas 5mg is used only after knowing the benefits to the mother exceed the risk to the fetus.
Breastfeeding should not be suggested

Storage

Everotas 5mg tablet store at 25°C.
Store the medicine away from moisture, heat, and light

Missed Dose

In the case of the missed dose, patients must consult with the medical practitioner and follow the instructions given by them. Thereby missed dose should be avoided and follow the regular dosing schedule.

FOR MORE INFORMATION:

EMAIL:

applepharmaceutical@gmail.com

PHONE:

91- 9987711567

VISIT US:

anti-cancer-drugs.com/everotas-5mg.php